Vaccine Development and Infectious Disease Challenge Study Services

Pharmaron’s specialist team has an in-depth understanding of the complexities of vaccine trials and infectious disease studies and is committed to helping clients make fast and accurate decisions about clinical development programs, while providing ongoing regulatory guidance.

Pharmaron’s infectious disease specialists at our Phase l Clinical Research Center (CPC) in Maryland, U.S., have completed over 50 vaccine studies. This includes viral/bacterial infection or challenge studies in campylobacter, cryptosporidium, malaria, cholera, influenza, CMV, streptococcus, staphylococcus, RSV, SARS-CoV-2 and norovirus.

• Experienced viral and bacterial challenge study site
• Isolation unit for participant and study separation
• Trial execution and study data analysis led by experienced board-certified infectious disease physicians

Site Safety and Proximity

• Site allows for isolation of vaccine and infectious disease studies to ensure subject safety and data integrity
• Close collaboration with local and nationally recognized academic and government clinical centers of excellence